218 related articles for article (PubMed ID: 23128807)
1. Carisoprodol: update on abuse potential and legal status.
Reeves RR; Burke RS; Kose S
South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807
[TBL] [Abstract][Full Text] [Related]
2. Carisoprodol: abuse potential and withdrawal syndrome.
Reeves RR; Burke RS
Curr Drug Abuse Rev; 2010 Mar; 3(1):33-8. PubMed ID: 20088817
[TBL] [Abstract][Full Text] [Related]
3. Carisoprodol legal status and patterns of abuse.
Fass JA
Ann Pharmacother; 2010 Dec; 44(12):1962-7. PubMed ID: 21062909
[TBL] [Abstract][Full Text] [Related]
4. Carisoprodol withdrawal after internet purchase.
Eleid MF; Krahn LE; Agrwal N; Goodman BP
Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570
[TBL] [Abstract][Full Text] [Related]
5. Effect of the market withdrawal of carisoprodol on use of other prescribed drugs with abuse potential.
Bramness JG; Furu K; Skurtveit S; Engeland A
Clin Pharmacol Ther; 2012 Mar; 91(3):438-41. PubMed ID: 22318620
[TBL] [Abstract][Full Text] [Related]
6. Impact of Schedule IV controlled substance classification on carisoprodol utilization in the United States: An interrupted time series analysis.
Li Y; Delcher C; Brown JD; Wei YJ; Reisfield GM; Winterstein AG
Drug Alcohol Depend; 2019 Sep; 202():172-177. PubMed ID: 31352307
[TBL] [Abstract][Full Text] [Related]
7. Is the frequency of carisoprodol withdrawal syndrome increasing?
Reeves RR; Hammer JS; Pendarvis RO
Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902
[TBL] [Abstract][Full Text] [Related]
8. Carisoprodol (soma): abuse potential and physician unawareness.
Reeves RR; Carter OS; Pinkofsky HB; Struve FA; Bennett DM
J Addict Dis; 1999; 18(2):51-6. PubMed ID: 10334375
[TBL] [Abstract][Full Text] [Related]
9. Carisoprodol (Soma): a new and cautious perspective on an old agent.
Littrell RA; Hayes LR; Stillner V
South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
[TBL] [Abstract][Full Text] [Related]
10. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
[TBL] [Abstract][Full Text] [Related]
11. Carisoprodol: a drug of continuing abuse.
Reeves RR; Pinkofsky HB; Carter OS
J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144
[TBL] [Abstract][Full Text] [Related]
12. Impairment due to intake of carisoprodol.
Bramness JG; Skurtveit S; Mørland J
Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209
[TBL] [Abstract][Full Text] [Related]
13. Somatic dysfunction during carisoprodol cessation: evidence for a carisoprodol withdrawal syndrome.
Reeves RR; Parker JD
J Am Osteopath Assoc; 2003 Feb; 103(2):75-80. PubMed ID: 12622352
[TBL] [Abstract][Full Text] [Related]
14. Is it time for carisoprodol to become a controlled substance at the federal level?
Reeves RR; Burke RS
South Med J; 2008 Feb; 101(2):127-8. PubMed ID: 18364610
[No Abstract] [Full Text] [Related]
15. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution.
McIntyre IM; Sherrard J; Lucas J
J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833
[TBL] [Abstract][Full Text] [Related]
16. [Centrally acting muscle relaxants and traffic hazards].
Bramness JG; Skurtveit S; Grung M; Mørland J
Tidsskr Nor Laegeforen; 2000 Jun; 120(17):1966-9. PubMed ID: 11008526
[TBL] [Abstract][Full Text] [Related]
17. Trends in carisoprodol abuse and misuse after regulatory scheduling: a retrospective review of California poison control calls from 2008 to 2015.
Sun C; Hollenbach KA; Cantrell FL
Clin Toxicol (Phila); 2018 Jul; 56(7):653-655. PubMed ID: 29228807
[TBL] [Abstract][Full Text] [Related]
18. The effect of scheduling and withdrawal of carisoprodol on prevalence of intoxications with the drug.
Høiseth G; Karinen R; Sørlid HK; Bramness JG
Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):345-9. PubMed ID: 19663822
[TBL] [Abstract][Full Text] [Related]
19. Carisoprodol withdrawal syndrome.
Reeves RR; Beddingfield JJ; Mack JE
Pharmacotherapy; 2004 Dec; 24(12):1804-6. PubMed ID: 15585447
[TBL] [Abstract][Full Text] [Related]
20. Commonly used muscle relaxant therapies for acute low back pain: a review of carisoprodol, cyclobenzaprine hydrochloride, and metaxalone.
Toth PP; Urtis J
Clin Ther; 2004 Sep; 26(9):1355-67. PubMed ID: 15530999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
